Improving Sleep for Healthy Hearts

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02848859
Collaborator
The Cleveland Clinic (Other)
34
1
2
21.1
1.6

Study Details

Study Description

Brief Summary

This is a pilot study randomizing patients with insomnia and coronary heart disease to either general sleep hygiene counseling and web-based cognitive behavioral therapy for insomnia versus general sleep hygiene counseling alone (followed by the cognitive behavioral therapy at a later date).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Go! to Sleep
  • Behavioral: General Sleep Education
N/A

Detailed Description

For this pilot study, the investigators will recruit up to 30 participants with insomnia and coronary heart disease. Another 30 patients will be recruited from another institution. Patients will be screened with a modified version of the Insomnia Severity Index (ISI), a brief self-report instrument validated for identifying insomnia. The investigators will modify the ISI to include exclusionary criteria. The investigators will randomize participants to 6 weeks of access to web based cognitive behavioral therapy for insomnia (wCBT-I) using an internet based CBT-I program plus education provided through access to the Harvard Sleep Education web site (which provides general sleep education information only) compared to 6 weeks of access to the Harvard Sleep Education web site, followed by access to the web-CBT program (a wait list control group). The investigators will test the hypothesis that use of wCBT-I improves sleep quality and sleep duration as measured by sleep diaries and the ISI. A secondary goal of the study is to assess the recruitment yields, retention and adherence rates.

Study Design

Study Type:
Interventional
Actual Enrollment :
34 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Improving Sleep for Healthy Hearts
Study Start Date :
Mar 1, 2015
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention: Go! to Sleep

We are using a web-based cognitive behavioral therapy program called Go! to Sleep. Go! to Sleep is an interactive online program developed by specialists in Cleveland Clinic's Wellness Institute and Sleep Disorders Center. The program is a 6 week self-help program that uses cognitive behavioral therapy techniques that have been proven to be effective in decreasing symptoms of insomnia.

Behavioral: Go! to Sleep
This is an online interactive program that delivers cognitive behavioral therapy for insomnia via the internet.
Other Names:
  • web-based cognitive behavioral therapy
  • Behavioral: General Sleep Education
    Providing patients information on healthy sleep and habits to promote healthy sleep.

    Placebo Comparator: General Sleep Hygiene Education

    General Sleep Hygiene Education is the first step in the treatment of any sleep disorder. Both arms will have access to a Harvard sleep education web site that provides general information about sleep as well as sleep hygiene.

    Behavioral: General Sleep Education
    Providing patients information on healthy sleep and habits to promote healthy sleep.

    Outcome Measures

    Primary Outcome Measures

    1. Change from baseline Insomnia Severity Index score at 6 weeks [At baseline, at 6 weeks, and in the treatment arm at 12 weeks.]

      It is a 7 item, validated questionnaire to determine severity of insomnia symptoms.

    Secondary Outcome Measures

    1. Change in sleep duration from baseline to 6 weeks [At baseline, at 6 weeks, and in the treatment arm at 12 weeks.]

      The investigators will use sleep diaries that participants fill out for 1 week at baseline and at 6 weeks to compare sleep duration between arms as well as at 12 weeks in the treatment arm only to assess duration of treatment effect.

    2. Change in mood assessed using the Patient Health Questionnaire-8 from baseline to 6 weeks [At baseline, at 6 weeks, and in the treatment arm at 12 weeks.]

      The investigators will use the Patient Health Questionnaire-8 to measure depressive symptoms

    3. Change in sleepiness assessed using the Epworth Sleepiness Questionnaire from baseline to 6 weeks [At baseline, at 6 weeks, and in the treatment arm at 12 weeks.]

      The investigators will use the Epworth Sleepiness questionnaire to measure sleepiness.

    4. Change in blood pressure from baseline to 6 weeks [At baseline and at 6 weeks]

      The investigators will measure seated blood pressure in triplicate and use the average of the latter two readings for blood pressure (taken at baseline and 6 week visits).

    5. Change in heart rate from baseline to 6 weeks [At baseline and at 6 weeks]

      The investigators will measure seated heart rate in triplicate and use the average of the latter two readings for heart rate(taken at baseline and 6 week visits).

    6. Change in Quality of life at baseline and 6 weeks [At baseline, at 6 weeks, and in the treatment arm at 12 weeks.]

      The investigators will measure this using the Duke Health Profile, another validated questionnaire to measure quality of life.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • meet criteria for at least mild insomnia based on the Insomnia Severity Index questionnaire results

    • have established coronary disease defined by: a) prior myocardial infarction or a coronary artery revascularization procedure; b) angiographically documented stenosis (>70%) of a major coronary artery; or c) prior ischemic stroke without major functional impairment.

    • minimum age of 18 years old.

    Exclusion Criteria:
    • no daily access to a computer with an internet connection

    • visual impairment preventing use of a computer

    • inability to read English

    • severe uncontrolled medical or psychiatric problems

    • heart failure with reduced ejection fraction <35%

    • high depressive symptoms (PHQ > 15)

    • drowsy driving

    • 3 days per week use of hypnotic medications

    • known untreated sleep disordered breathing, narcolepsy, or restless leg syndrome

    • shift-workers

    • prior exposure to CBT-I treatment

    • dialysis patient

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Brigham and Womens Hospital Boston Massachusetts United States 02115

    Sponsors and Collaborators

    • Brigham and Women's Hospital
    • The Cleveland Clinic

    Investigators

    • Principal Investigator: Susan Redline, MD, MPH, Brigham and Women's Hospital
    • Study Director: Sogol Javaheri, MD, MA, Brigham and Women's Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Susan Redline, Senior Physician, Division of Sleep and Circadian Disorders, Brigham and Women's Hospital
    ClinicalTrials.gov Identifier:
    NCT02848859
    Other Study ID Numbers:
    • 2014P000845
    First Posted:
    Jul 29, 2016
    Last Update Posted:
    Feb 23, 2017
    Last Verified:
    Feb 1, 2017
    Keywords provided by Susan Redline, Senior Physician, Division of Sleep and Circadian Disorders, Brigham and Women's Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 23, 2017